Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Cyano-borohydride | HCID 498716 | — |
| Reactant | HCID 66764697 | HCID 66764697 | — |
| Reactant | HCID 87139712 | HCID 87139712 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 131731434 | HCID 131731434 | 132.1% |
Reaction Steps
To a solution of 4-(2-oxo-1-oxa-3,8-diazaspiro[4.5]dec-3-yl)benzoic acid (27 mg, 0.087 mmol) (from Example 5-1, Step 4) and 2,6-dichloro-2′,4′-difluorobiphenyl-4-carboxaldehyde (20 mg, 0.070 mmol) (from Step 3) in DMF (2 mL) in a 20 mL scintillation vial was added acetic acid (13 uL, 0.209 mmol) and MP-cyanoborohydride resin (56 mg, 0.140 mmol, 2.49 mmol/g). The mixture was shaken at room temperature for 20 hours and then was filtered to remove the resin and washed with acetonitrile/water. The mixture was acidified with TFA and used directly for reverse phase (C-18) HPLC chromatography (10-55% acetonitrile/water gradient, 0.1% TFA) to afford the desired title compound (27 mg) as a solid TFA salt. The TFA salt was converted to the title compound hydrochloride salt by taking up in DCM and addition of excess 2M hydrogen chloride in ether and evaporation (twice) followed by trituration with ether to give the HCl salt (24 mg) as a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08742110B2 |
|---|
| Source dataset | uspto-grants-2014_06 |
|---|
| ORD ID | ord-ac03afe27d4640928e0d94ef92f2748c |
|---|
| Source note | uspto-grants-2014_06 |
|---|